$LIF

Life360 (LIF) director turns 33,972 options into stock

Life360 (LIF) director Synge James exercised 33,972 stock options on August 19, 2026, converting them into common shares at exercise prices of $13.35 and $8.19. The options were fully vested. James's holdings include 4,600 RSUs and shares underlying Chess Depositary Interests, which trade on the Australian Securities Exchange.

Original reporting
Published Aug 21, 2026, 8:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 10:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$LIF
Neutral
high confidence
Mentioned
$LIF
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$LIFNeutralLow
01

Why it matters

The insider buy modestly increases insider ownership, offering a slight confidence signal but unlikely to move the stock materially.

02

Market read

Primary disclosure of a small insider purchase; limited trading relevance.

03

What to watch

Potential future dilution from RSUs and CDIs, and the director's longer‑term strategic insight not reflected in the small transaction.

Relevance 4/10Novelty 5/10Timing: recent insider purchase reported

Background

Form 4 filing discloses a director's option exercises and share conversion for Life360, Inc.

Company-level read

Ticker impact

$LIFNeutralHigh confidence
Context

Director Synge James exercised 33,972 fully‑vested options, converting them into common shares on Aug 19, 2026.

Expected impact

Minimal short‑term price movement; likely absorbed without significant volatility.

Evidence & confidence

The transaction size (~$340k) is small relative to market cap; director ownership increase is modest and fully vested.

Market effects

None significant; reflects standard insider activity in the consumer tech sector.

Limited to US investors tracking Life360; no broader regional effect.

Minimal; does not influence global market trends.

Counterpoint

The director's purchase could signal undervaluation, suggesting a potential upside if the market overlooks it.

Key entities

  • Life360, Inc.

    US‑listed consumer‑tech firm (ticker LIF).

  • Synge James

    Director of Life360 who exercised options.

Related articles

$LIFMed

Why Life360 Stock Is Plunging Lower This Week

Life360 (NASDAQ: LIF) shares fell about 18% after Q2 results despite beating analyst expectations. The company reported Q2 sales up 38% and MAUs up 16% to over 100 million, with advertising revenue quadrupling to 14% of sales. Management did not raise full-year guidance, and the stock trades around 45x free cash flow.

$LIFMedAI 8/10

Life360 (LIF) Q2 2026 Earnings Call Transcript

Life360 (LIF) reported Q2 2026 revenue of $159.0 million, up 38% year over year, driven by $115.6 million subscription revenue (+31%) and $22.0 million advertising revenue (+315%) after Nativo integration. MAU rose to 102.4 million (+16%). Adjusted EBITDA was $31.1 million (+53%). Full-year subscription guidance raised to $475-$480 million; revenue $650-$685 million.

$LIFMed

Why Life360 Stock Is Crashing Today

Life360 (NASDAQ: LIF) shares fell 25.7% Tuesday after the company reported Q2 results. Q2 revenue rose 38% to $159 million, while GAAP EPS fell to $0.06. Management kept full-year revenue and profit guidance unchanged, adjusting subscription and retail hardware targets. CFO Russell Burke said AI-native transition should drive operating leverage starting in 2027.

$LIFMed

Why Life360 Stock Is Plunging Lower This Week

Life360 (LIF) shares fell about 18% for the week after the company reported Q2 earnings. According to Life360, Q2 revenue rose 38%, MAUs grew 16% to over 100 million, and adjusted EBITDA increased 53%. The stock dropped despite beating analyst expectations because management did not raise full-year guidance.

$LIFMedAI 8/10

Life360 Q2 Results: Revenue rises 38% YoY, but stock falls 25%

Life360 Inc. (NASDAQ: LIF) shares fell about 25% to $50.20 after Q2 results beat estimates but the company kept fiscal 2026 revenue guidance at $650 million to $685 million, below the $670.24 million analyst midpoint. Q2 EPS was $0.06 vs $0.01; revenue was $158.96 million vs $156.39 million. Advertising revenue hit $22 million.

$LIFMed

Why Is Life360 Stock Falling Tuesday? - Life360 (NASDAQ:LIF)

Life360 (LIF) reported Q2 EPS of $0.06, above the $0.01 estimate, and revenue of $158.96 million versus $156.39 million. The company kept fiscal 2026 revenue guidance at $650 million to $685 million, below the $670.24 million analyst midpoint. Evercore cut its price target to $66 from $68; shares fell to about $50.20.